Definium Therapeutics develops psychedelic-based therapeutics for psychiatric and neurological disorders. Backed by North Carolina Biotechnology Center.
About the role
Together we are moving psychiatry forward—beyond better, into a boundless future. Join us! Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- Partner with business and technology leaders to define an enterprise digital innovation strategy aligned with Definium’s 3-5 year growth and commercialization plans
- Assess current digital capabilities, platforms, vendors, consultants, AI initiatives, and spend, identify gaps, overlap, underutilized capabilities, and opportunities to simplify
- Build and maintain a prioritized multi-year roadmap that sequences investments based on business value, readiness, risk, and scalability
- Continuously benchmark emerging practices across biotech, specialty pharma, and adjacent industries, separating durable opportunities from technology hype
- Partner with Commercial, Market Access, Patient Services, Medical Affairs, and Enterprise Technology to define capabilities required for launch readiness and post-launch operations
- Help shape the future digital patient and provider experience, including capabilities supporting patient services, reimbursement, engagement, adherence, and omnichannel interactions
More about this role
Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.
Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq...
Browse similar: Startup jobs · Remote jobs